Forskning ved Københavns Universitet - Københavns Universitet

Forside

Body mass index and participation in organized mammographic screening: a prospective cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Body mass index and participation in organized mammographic screening : a prospective cohort study. / Hellmann, Sophie Sell; Njor, Sisse Helle; Lynge, Elsebeth; von Euler-Chelpin, My; Olsen, Anja; Tjønneland, Anne; Vejborg, Ilse; Andersen, Zorana Jovanovic.

I: B M C Cancer, Bind 15, Nr. 294, 17.04.2015, s. 1-9.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Hellmann, SS, Njor, SH, Lynge, E, von Euler-Chelpin, M, Olsen, A, Tjønneland, A, Vejborg, I & Andersen, ZJ 2015, 'Body mass index and participation in organized mammographic screening: a prospective cohort study', B M C Cancer, bind 15, nr. 294, s. 1-9. https://doi.org/10.1186/s12885-015-1296-8

APA

Hellmann, S. S., Njor, S. H., Lynge, E., von Euler-Chelpin, M., Olsen, A., Tjønneland, A., ... Andersen, Z. J. (2015). Body mass index and participation in organized mammographic screening: a prospective cohort study. B M C Cancer, 15(294), 1-9. https://doi.org/10.1186/s12885-015-1296-8

Vancouver

Hellmann SS, Njor SH, Lynge E, von Euler-Chelpin M, Olsen A, Tjønneland A o.a. Body mass index and participation in organized mammographic screening: a prospective cohort study. B M C Cancer. 2015 apr 17;15(294):1-9. https://doi.org/10.1186/s12885-015-1296-8

Author

Hellmann, Sophie Sell ; Njor, Sisse Helle ; Lynge, Elsebeth ; von Euler-Chelpin, My ; Olsen, Anja ; Tjønneland, Anne ; Vejborg, Ilse ; Andersen, Zorana Jovanovic. / Body mass index and participation in organized mammographic screening : a prospective cohort study. I: B M C Cancer. 2015 ; Bind 15, Nr. 294. s. 1-9.

Bibtex

@article{b6ab9ce47fb94b7fb51812cb54b6bc94,
title = "Body mass index and participation in organized mammographic screening: a prospective cohort study",
abstract = "BACKGROUND: Breast cancer is the leading cancer among women, and early diagnosis is essential for future prognosis. Evidence from mainly cross-sectional US studies with self-reported exposure and outcome found positive association of body mass index (BMI) with non-participation in mammographic screening, but hardly addressed the influence of potential effect-modifiers. We studied the association between objective measures of BMI and participation in mammographic screening in a Danish prospective cohort, and explored the influence of menopausal status, hormone therapy (HT), previous screening participation, and morbidities on this relationship.METHODS: A total of 5,134 women from the Diet, Cancer, and Health cohort who were invited to population based mammographic screening in Copenhagen were included in analysis. Women were 50-64 years old at inclusion (1993-97) when their height and weight were measured and covariates collected via questionnaire. Odds ratios (OR) and 95{\%} confidence intervals (CI) for the association between BMI and mammographic screening participation were estimated by logistic regression, adjusted for other breast cancer risk factors and morbidities. Effect modification was evaluated by an interaction term and tested by Wald test.RESULTS: Underweight (BMI < 18.5 kg/m(2), OR: 95{\%} CI; 2.24: 1.27-3.96) and obese women of class II (BMI 35-40 kg/m(2), 1.54: 0.99-2.39) and III (BMI ≥ 40 kg/m(2), 1.81: 0.95-3.44) had significantly higher odds of non-participation than women with normal weight. This association was limited to postmenopausal women (Wald test p = 0.08), with enhanced non-participation in underweight (2.83: 1.52-5.27) and obese women of class II and III (1.84: 1.15-2.95; 2.47: 1.20-5.06) as compared to normal weight postmenopausal women. There was no effect modification by HT, previous screening participation, or morbidities, besides suggestive evidence of enhanced non-participation in diabetic overweight and obese women.CONCLUSIONS: Underweight and very obese postmenopausal women were significantly less likely to participate in mammographic screening than women with normal weight, while BMI was not related to screening in premenopausal women. Effect of BMI on mammographic screening participation was not significantly modified by HT, previous screening participation, or morbidities.",
author = "Hellmann, {Sophie Sell} and Njor, {Sisse Helle} and Elsebeth Lynge and {von Euler-Chelpin}, My and Anja Olsen and Anne Tj{\o}nneland and Ilse Vejborg and Andersen, {Zorana Jovanovic}",
year = "2015",
month = "4",
day = "17",
doi = "10.1186/s12885-015-1296-8",
language = "English",
volume = "15",
pages = "1--9",
journal = "B M C Cancer",
issn = "1471-2407",
publisher = "BioMed Central Ltd.",
number = "294",

}

RIS

TY - JOUR

T1 - Body mass index and participation in organized mammographic screening

T2 - a prospective cohort study

AU - Hellmann, Sophie Sell

AU - Njor, Sisse Helle

AU - Lynge, Elsebeth

AU - von Euler-Chelpin, My

AU - Olsen, Anja

AU - Tjønneland, Anne

AU - Vejborg, Ilse

AU - Andersen, Zorana Jovanovic

PY - 2015/4/17

Y1 - 2015/4/17

N2 - BACKGROUND: Breast cancer is the leading cancer among women, and early diagnosis is essential for future prognosis. Evidence from mainly cross-sectional US studies with self-reported exposure and outcome found positive association of body mass index (BMI) with non-participation in mammographic screening, but hardly addressed the influence of potential effect-modifiers. We studied the association between objective measures of BMI and participation in mammographic screening in a Danish prospective cohort, and explored the influence of menopausal status, hormone therapy (HT), previous screening participation, and morbidities on this relationship.METHODS: A total of 5,134 women from the Diet, Cancer, and Health cohort who were invited to population based mammographic screening in Copenhagen were included in analysis. Women were 50-64 years old at inclusion (1993-97) when their height and weight were measured and covariates collected via questionnaire. Odds ratios (OR) and 95% confidence intervals (CI) for the association between BMI and mammographic screening participation were estimated by logistic regression, adjusted for other breast cancer risk factors and morbidities. Effect modification was evaluated by an interaction term and tested by Wald test.RESULTS: Underweight (BMI < 18.5 kg/m(2), OR: 95% CI; 2.24: 1.27-3.96) and obese women of class II (BMI 35-40 kg/m(2), 1.54: 0.99-2.39) and III (BMI ≥ 40 kg/m(2), 1.81: 0.95-3.44) had significantly higher odds of non-participation than women with normal weight. This association was limited to postmenopausal women (Wald test p = 0.08), with enhanced non-participation in underweight (2.83: 1.52-5.27) and obese women of class II and III (1.84: 1.15-2.95; 2.47: 1.20-5.06) as compared to normal weight postmenopausal women. There was no effect modification by HT, previous screening participation, or morbidities, besides suggestive evidence of enhanced non-participation in diabetic overweight and obese women.CONCLUSIONS: Underweight and very obese postmenopausal women were significantly less likely to participate in mammographic screening than women with normal weight, while BMI was not related to screening in premenopausal women. Effect of BMI on mammographic screening participation was not significantly modified by HT, previous screening participation, or morbidities.

AB - BACKGROUND: Breast cancer is the leading cancer among women, and early diagnosis is essential for future prognosis. Evidence from mainly cross-sectional US studies with self-reported exposure and outcome found positive association of body mass index (BMI) with non-participation in mammographic screening, but hardly addressed the influence of potential effect-modifiers. We studied the association between objective measures of BMI and participation in mammographic screening in a Danish prospective cohort, and explored the influence of menopausal status, hormone therapy (HT), previous screening participation, and morbidities on this relationship.METHODS: A total of 5,134 women from the Diet, Cancer, and Health cohort who were invited to population based mammographic screening in Copenhagen were included in analysis. Women were 50-64 years old at inclusion (1993-97) when their height and weight were measured and covariates collected via questionnaire. Odds ratios (OR) and 95% confidence intervals (CI) for the association between BMI and mammographic screening participation were estimated by logistic regression, adjusted for other breast cancer risk factors and morbidities. Effect modification was evaluated by an interaction term and tested by Wald test.RESULTS: Underweight (BMI < 18.5 kg/m(2), OR: 95% CI; 2.24: 1.27-3.96) and obese women of class II (BMI 35-40 kg/m(2), 1.54: 0.99-2.39) and III (BMI ≥ 40 kg/m(2), 1.81: 0.95-3.44) had significantly higher odds of non-participation than women with normal weight. This association was limited to postmenopausal women (Wald test p = 0.08), with enhanced non-participation in underweight (2.83: 1.52-5.27) and obese women of class II and III (1.84: 1.15-2.95; 2.47: 1.20-5.06) as compared to normal weight postmenopausal women. There was no effect modification by HT, previous screening participation, or morbidities, besides suggestive evidence of enhanced non-participation in diabetic overweight and obese women.CONCLUSIONS: Underweight and very obese postmenopausal women were significantly less likely to participate in mammographic screening than women with normal weight, while BMI was not related to screening in premenopausal women. Effect of BMI on mammographic screening participation was not significantly modified by HT, previous screening participation, or morbidities.

U2 - 10.1186/s12885-015-1296-8

DO - 10.1186/s12885-015-1296-8

M3 - Journal article

C2 - 25880028

VL - 15

SP - 1

EP - 9

JO - B M C Cancer

JF - B M C Cancer

SN - 1471-2407

IS - 294

ER -

ID: 135648807